Intelligence / Healthtech / Health Funding Register / DexCare, Inc.
Fundingraised $12.9M14 Sept 2026
DexCare, Inc.
14 Sept 2026: Raised $12.9M · Seattle, WA. Recorded in the SEC Form D data sets.
- Filed
- 14 Sept 2026
- Location
- Seattle, WA
- State
- Washington
- Industry
- Other Health Care
- Amount raised
- $12.9M
- Offering size
- $22.7M
- Revenue range
- Decline to Disclose
- Entity type
- Corporation
- Jurisdiction
- Delaware
- First sale
- 2026-08-28
- Securities
- Equity
- Investors so far
- 14
- SEC CIK
- 0001843308
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at DexCare, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Washington
Health Funding Register
28 SeptQ-Immune, Inc.raised $25K · Seattle, WAFunding22 SeptSeattle Neurosound Solutions, Inc.raised $100K · Seattle, WAFunding15 SeptHexamer Therapeutics, Incraised $500K · Pullman, WAFunding26 AugAptevo Therapeutics Inc.raised $3.5M · Seattle, WAFunding25 AugMalarVx, Inc.raised $125K · Seattle, WAFunding14 AugStrella Biotechnology, Inc.raised $1.8M · Seattle, WAFunding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.